Clinical Trial Update: Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules [NA]

View source ↗

Summary

This clinical trial investigates whether plasma metabolomics can distinguish PET-positive malignant nodules from PET-positive benign nodules in patients with so…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Solitary Pulmonary Nodules

Snippet

Sponsor: Hasselt University | Conditions: Solitary Pulmonary Nodules, Lung Cancer | NA | Status: RECRUITING